NIH Seeks to Fund MDx, Biomarker Development for Liver Diseases | GenomeWeb

NEW YORK (GenomeWeb News) — The National Institutes of Health plans to fund small businesses that will develop technologies for advancing the means of diagnosing, treating, and preventing liver disease, including biomarker research, and molecular diagnostics and reagents, among others.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.